1. The World Market for Transdermal Drug Delivery
Report Details:
Published:September 2012
No. of Pages: 100
Price: Single User License – US$2500
Transdermal (and related transmucosal) drug delivery is a well-established accepted route of
administration for therapeutically beneficial medicines. There is no potential limit for the
therapeutic area for development of transdermal systems. Some therapeutic areas stand out,
including sex hormones and pain management, due to the successful combination of the individual
drug molecules and available product technologies. The potential benefits that may be achieved
using transdermal delivery include continuous, controlled release and absorption of medication
into the body, avoiding presystemic metabolism that may occur following oral dosing, including
both intestinal and hepatic first-pass metabolism, improving patient compliance by offering more
convenient dosing regimens , such as once or twice weekly dosing, and the ability to quickly
discontinue treatment by removal of the system.
This report, World Markets for Transdermal Drug Delivery is a comprehensive look at the
transdermal/transmucosal drug delivery market is divided into two sections. The first section
encompasses the pharmaceutical products that utilize the drug delivery technology. The second
section encompasses drug delivery technology and the revenues earned from licensing that
technology. Because drug delivery technology is an integral part of sales of pharmaceuticals and
drug delivery technology cannot exist without pharmaceuticals, revenues have been reported that
include pharmaceutical sales for products utilizing that technology.
This market is divided into two segments:
•Market Size and Forecast for Transdermal Drug Delivery
•Market Size and Forecast for Transmucosal Drug Delivery
•Market Breakout by Region (US, Europe, Japan, ROW)
•Review of Products on the Market
•Market Breakout by Disease Treated (Cardiovascular, Hormones, Pain Management, Smoking
Cessation, Other)
•Market Breakout by Technology Revenues and Pharmaceutical Component Revenues
•Profiles of Companies in the Market
The research conducted by Kalorama included comprehensive research of secondary sources
such as company literature, databases, investment reports, and medical and business journals.
New technologies, market developments, and research and development trends and expenditures

2. were identified through patent and database searches, as well as via interviews with key
personnel. Person-to-person and telephone interviews were the primary method of gathering
information. E-mail correspondence was also used in the interview process. Interviews with 18 key
industry officials, trade association representatives, consultants, healthcare providers, and
government personnel were compiled to form the primary basis of information—particularly
revenue and market share data—presented in this report.
All market data pertain to the worldwide market at the manufacturers’ level and presented in U.S.
dollars. The base year for data was 2012. Historical data are provided for 2010 through 2011, with
forecast data provided for 2013 through 2017. Compound annual growth rates (CAGR) are
provided for the 2010-2012, 2012-2017, and 2010–2017 periods.
The following companies are profiled in this report
•3M Pharmaceuticals
•Access Pharmaceuticals, Inc.
•Acrux Limited
•ALZA Corporation
•Antares Pharma, Inc.
•Apricus BioSciences
•Aveva Drug Delivery Systems
•Generex Biotechnology Corporation
•Inovio Pharmaceuticals, Inc.
•Labtec GmbH
•Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
•NITTO DENKO CORPORATION
•Noven Pharmaceuticals, Inc.
•Pantec Biosolutions AG
•Tapemark
•TEVA Pharmaceutical Industries Ltd.
•Zosano Pharma
Get your copy of this report @
http://www.reportsnreports.com/reports/195651-the-world-market-for-transdermal-drug-delivery.html
Major points covered in Table of Contents of this report include
Table Of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
Market Drivers
Market Size and Growth
Total Transdermal/Transmucosal Drug Delivery Market
Transdermal/Transmucosal Drug Delivery Only Market
Competitive and Market Analysis

3. CHAPTER TWO: INTRODUCTION AND OVERVIEW
Scope and Methodology
Reasons for Transdermal/Transmucosal Drug Delivery Systems
Phases of Drug Action
Transdermal drug Delivery
History of Transdermal Drug Delivery
Advantages of Transdermal Drug Delivery
Disadvantages of Transdermal Drug Delivery
Transdermal Patch (Passive) Drug Delivery
Transfersomes
Medicated Tattoos
Crystal Reservoir Technology
Active Transdermal Drug Applications
Electrotransport Drug Delivery
Iontophoresis
Reverse Iontophoresis
Sonophoresis
Photomechanical Waves
Transmucosal Drug Delivery
Buccal Drug Delivery
Vaginal Drug Delivery
CHAPTER THREE: TRENDS AND DEVELOPMENTS
Novel Transdermal Approvals
Innovations in Transdermal Drug Delivery
Adhesive Technology and Issues
Adhesive Market Issues
Generic Transdermal Study Design Guidelines
Biotechnological Issues
Developments in Insulin Delivery
New Developments in Hormone Drug Delivery
New Mucosal/Buccal Delivery Systems
Other New Drug Delivery Systems
Microneedle-Assisted Transdermal Drug Delivery
Controlled Thermal Energy Technology
New Ultrasound Technology
Transdermal Products in Development
CHAPTER FOUR: MARKET SIZE AND GROWTH
The Total Transdermal/Transmucosal Drug Delivery Market
Transdermal/Transmucosal Delivery Technology Only Market

4. CHAPTER FIVE: COMPETITIVE ANALYSIS
Competitive Landscape
Emerging Participants
Market Analysis
CHAPTER SIX: COMPANY PROFILES
3M Pharmaceuticals
Access Pharmaceuticals, Inc.
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences
Aveva Drug Delivery Systems
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Labtec GmbH
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
NITTO DENKO CORPORATION
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
APPENDIX: COMPANY DIRECTORY
Table Of Exibits
CHAPTER TWO: INTRODUCTION AND OVERVIEW
Table 2-2: Select Leading Transdermal Delivery-Based Products
CHAPTER THREE: TRENDS AND DEVELOPMENTS
Table 3-1: Selected Transdermal Products in Development
CHAPTER FOUR: MARKET SIZE AND GROWTH
Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and
Pharmaceuticals 2010-2017
Figure 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and
Pharmaceuticals 2010-2017
Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmusal Drug
Delivery Systems by Type 2010–2017
Figure 4-2: The Worldwide Market for Pharmaceuticals UtilizingTransdermal/Transmucosal Drug
Delivery Systems Revenues by Type 2010–2017

5. Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug
Delivery Technologies Market Share by Type 2010-2017
Figure 4-3: Transdermal Drug Delivery Market by Disease Treated (Cardiovascular, Hormones,
Pain Management, Smoking Cessation, Other)
Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by
Region (United States, Europe, Japan, ROW) 2010–2017
Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by
Pharmaceutical and Drug Delivery Component 2010-2017
Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems
Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010-2017
Figure 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems
Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010-2017
Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems
Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2012
Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems
Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2017
CHAPTER FIVE: COMPETITIVE ANALYSIS
Table 5-1: Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology
Contact: sales@reportsandreports.com for more information.